EL7.AI
Strategy BuilderCOT DataAdvanced NewsResearchNewEarnings CalendarEconomic Calendar
We use cookiesPrivacy Policy
EL7.AIEL7.AI

AI Financial Intelligence
Professional analysis of central bank decisions

© 2026 EL7.AI. All rights reserved.

Markets

  • News
  • Forex
  • Stocks
  • Crypto
  • Gold
  • Commodities
  • Indices
  • ETFs

Analysis

  • Fed
  • ECB
  • BLS
  • COT
  • Economic Calendar

Learn

  • Service Guide
  • Oil

Company

  • About
  • Contact
  • Data Methodology
  • AI Disclosure
  • Pricing
  • Enterprise
  • Terms
  • Privacy
  • Security
  • WhatsApp
Status data is currently unavailable

The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

Home
Stocks
Fortress Biotech, Inc.
EL7 Factor Analysis
How we score this
Overall30
Weak — below market medianContrarianF 5/9DistressBetter than 30% of Market stocks, per EL7's model
FactorScoreDistributionValueAvgRank
▸
Valuation
95
0.9x▲17.6xTop tier
▸
Growth
84
15.5%▲7.1%Top tier
▸
Quality
76
-21.2%▼4.5%Top tier
▸
Safety
42
—2.6xAround median
▸
Capital Return
63
0.84%▼2.15%Around median
▸
Momentum
27
-15.2%▼2.3%Bottom tier
▸
Sentiment
23
1▼3Bottom tier

Frequently Asked Questions

What is Fortress Biotech, Inc. stock?▼

Fortress Biotech, Inc. is a publicly traded stock representing ownership in the company, giving holders rights to dividends and voting.

How can I invest in Fortress Biotech, Inc.?▼

You can buy Fortress Biotech, Inc. shares through a licensed brokerage. Research the company's financials before investing.

What are the key metrics for evaluating Fortress Biotech, Inc.?▼

Key metrics include Price-to-Earnings (P/E) ratio, Return on Equity (ROE), revenue growth, and net profit margin.

Does Fortress Biotech, Inc. pay dividends?▼

Dividend policies vary by company. Check the dividends section on the stock page for the payout history.

What are the risks of investing in Fortress Biotech, Inc.?▼

Risks include market volatility, sector-specific risks, regulatory changes, and company financial performance. Diversification helps reduce risk.

FBIO

FBIO Fortress Biotech, Inc.

Fortress Biotech, Inc. · NASDAQ
Market Open
2.51
▲ ⁦+0.00%⁩ (0.00)
Market Cap$83.4M
Beta1.19
52w Low52w High
2.184.53
Last Week
⁦-0.40%⁩
Last Month
⁦-13.75%⁩
Last 3 Months
⁦-18.24%⁩
Last Year
⁦-26.82%⁩
Fair Value
Low confidenceCurrent price$2.51
Analyst target · 1 analysts
$5.00
⁦+99%⁩
See it clearly undervalued
Range ⁦$5.00–$5.00⁩
vs
DCF (estimate)
$91
⁦+3515%⁩
Sees it clearly undervalued
⁦9.7⁩% discount · ⁦11⁩% growth
Bottom lineThe two methods broadly agree — estimate range ⁦$5.00–$91⁩.

Estimates — analyst targets and a simplified DCF, not investment advice.

Compare in the screener

AI analysis from the earnings call, financials and news

Analyst Consensus

This section combines price targets, revision history, analyst coverage changes, and an AI summary of what changed on the Street.

Price Target· 1 analysts setting price target
$5.00
⁦+99.2%⁩
Current Price $2.51·Median $5.00
Low
$5.00
High
$5.00
Street summary

Fortress Biotech (FBIO) Stock Forecast Analysis

Bullish tilt

Fortress Biotech stock shows complete stability in its target price at 5 dollars over the last 30 days, with zero Dispersion among analysts due to only one analyst currently covering the stock in the updated data. This stability reflects theoretical optimism with a positive price gap compared to the current price (2.74 dollars), but simultaneously indicates a decrease in the depth of analytical coverage for the stock.

As of 2026-05-25
Revisions momentum · 30d
⁦0.0%⁩
Average rating
★ 4.00
Buy
Analyst coverage
2
Buy conviction
100%
High
Target dispersion
0%
Analyst ratings over time2 analysts rating
2
Strong BuyBuyHoldSellStrong Sell
Rating trend — last 12 months4.33 → 4.00
Recent analyst moves
  • = Reiterate2026-05-18
    Industrial Alliance Securities
    —· $5.00
  • = Reiterate2026-05-18
    Citigroup
    Buy
  • = Reiterate2024-04-09
    H.C. Wainwright
    Buy
Premium content
Key Financials

Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.

StockSector medianSector averagetypical sector range
MetricValuePosition within sectorVerdict
  • P/E (TTM)
    0.93x
    3.68x44.95x
    Very cheap
  • Forward P/E
    8.29x
    4.70x37.61x
    Very cheap
  • EV / EBITDA
    —
    —
  • FCF Yield
    150.5%
    -145.2%7.8%
    Exceptional
  • Revenue Growth YoY
    15.5%
    -57.4%93.8%
    Near median
  • EPS Growth YoY
    384.2%
    -159.3%129.8%
    Exceptional
  • Gross Margin
    65.6%
    12.8%90.7%
    Above average
  • ROIC
    -21.2%
    -154.2%16.1%
    Strong
  • Net Debt / EBITDA
    —
    —
  • Dividend Yield
    0.8%
    0.0%4.0%
    Low
  • Payout Ratio
    0.8%
    7.4%76.0%
    Low
  • Altman Z-Score
    -1.70
    -36.5017.81
    Above average
Financial Analysis
|